Asf, No worries. We look like we have picked a real winner with this one. Commentators love the business model. After so many years of seeing failures in the Lab to Market approach, with a couple winners but millions or more likely billions down the toilet trying to get over the line.
To see a company that has 3 and soon to be 6 big pharma deals, cash flow positive 2011/12 years, and hundres of millions in milestones lining up must be resfreshing to wisened old market watchers.
This company could appeal to more conservative investors.
We will know before xmas, maybe a real celebration coming this year.
PoS
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.030(2.21%) |
Mkt cap ! $801.9M | |||
| Open | High | Low | Value | Volume |
| $1.39 | $1.39 | $1.33 | $103.4K | 75.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2600 | $1.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |